Assessing systemic arterial hypertension through echocardiography: a review for the clinician.

Curr Hypertens Rev

Division of Clinical Cardiology and Echocardiography, Catarinense Center of Cardiology; Florianopolis, Brazil; Address: 486 Osmar Cunha Avenue Florianopolis-SC, Brazil Zip Code: 88015-100.

Published: July 2015

Hypertension is a major cardiovascular (CV) risk factor and elevated blood pressure poses a significant burden for the whole CV hemodynamics. Along the last decades different techniques and resources have been developed, including ultrasound´s M-mode and B-mode, spectral Doppler, tissue Doppler and color Doppler. Techniques from newer resources as speckle tracking, twist and tridimensional ultrasound are continuously being inserted in the echocardiography labs routine around the world. Many of the older and newer techniques interpretation have a subject component from the echocardiographer. The clinician must have minimum technical echocardiography knowledge and assess if the echocardiogram data match clinical and other exams data. Systemic arterial hypertension leads to morphologic and hemodynamic changes in the heart. These changes are signals of progressive damage along the years. Echocardiography is a powerful tool to assess these diagnostic and prognostic information.

Download full-text PDF

Source
http://dx.doi.org/10.2174/157340211001141111145152DOI Listing

Publication Analysis

Top Keywords

systemic arterial
8
arterial hypertension
8
assessing systemic
4
echocardiography
4
hypertension echocardiography
4
echocardiography review
4
review clinician
4
clinician hypertension
4
hypertension major
4
major cardiovascular
4

Similar Publications

Rheumatoid arthritis (RA) is a chronic autoimmune disease marked by systemic inflammation. While RA primarily affects the joints, its systemic effects may lead to an increased cerebro- and cardiovascular risk. Atherosclerosis of the carotid arteries is a significant risk factor for cerebrovascular events and serves as a surrogate marker for cardiovascular risk.

View Article and Find Full Text PDF

Prediction of pre-eclampsia using maternal hemodynamic parameters at 12 + 0 to 15 + 6 weeks.

Ultrasound Obstet Gynecol

January 2025

Department of Obstetrics and Gynaecology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, SAR, China.

Objectives: To compare the maternal hemodynamic profile at 12 + 0 to 15 + 6 weeks' gestation in women who subsequently developed pre-eclampsia (PE) and those who did not, and to assess the screening performance of maternal hemodynamic parameters for PE in combination with the Fetal Medicine Foundation (FMF) triple test, including maternal factors (MF), mean arterial pressure (MAP), uterine artery pulsatility index and placental growth factor.

Methods: This was a prospective case-control study involving Chinese women with a singleton pregnancy who underwent preterm PE screening at 11 + 0 to 13 + 6 weeks' gestation using the FMF triple test, between February 2020 and February 2023. Women identified as being at high risk (≥ 1:100) for preterm PE by the FMF triple test were matched 1:1 with women identified as low risk (< 1:100) for maternal age ± 3 years, maternal weight ± 5 kg and date of screening ± 14 days.

View Article and Find Full Text PDF

Background: Low-volume hypertonic solutions, such as half-molar lactate (LAC), may be a potential treatment used for fluid resuscitation. This study aimed to evaluate the underlying cardiovascular effects and mechanisms of LAC infusion compared to sodium-matched hypertonic sodium chloride (SAL).

Methods: Eight healthy male participants were randomized in a controlled, single-blinded, crossover study.

View Article and Find Full Text PDF

Metabolic cardiomyopathy associated with a compound heterozygous variant in NAD(P)HX dehydratase: a case report and literature review.

Transl Pediatr

December 2024

Department of Pediatric Intensive Care Unit, National Regional Medical Center, Guizhou Branch of Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Guizhou Provincial People's Hospital, Guiyang, China.

Background: Metabolic cardiomyopathy is characterized by structural and functional changes to the heart and interstitial fibrosis without coronary artery disease or hypertension. Inborn metabolic defects are a common cause of cardiomyopathy in children. There are more than 40 kinds of inborn metabolic defects that cause cardiomyopathy.

View Article and Find Full Text PDF

Behçet's disease (BD) is a chronic, relapsing, systemic vasculitis of unknown etiology that affects blood vessels of all sizes, potentially leading to severe complications such as coronary artery aneurysms. This report describes the case of a 33-year-old woman with BD who presented with recurrent chest pain. Imaging revealed a large saccular aneurysm in the left anterior descending artery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!